HomeGeneticsConditionPurine nucleoside phosphorylase deficiency
Back to Condition
Purine nucleoside phosphorylase deficiency
Reviewed by Medicinsk Expert•Last updated: 2026-10-22•Condition

Purine nucleoside phosphorylase deficiency

Purine nucleoside phosphorylase deficiency is a rare immunodeficiency characterized by low T cells and sometimes B cells, leading to repeated and life-threatening infections, often accompanied by neurological problems.

Overview

Purine nucleoside phosphorylase deficiency is a disorder of the immune system called an immunodeficiency. Immunodeficiencies are conditions in which the immune system is not able to protect the body effectively from foreign invaders such as bacteria and viruses.

People with purine nucleoside phosphorylase deficiency have low numbers of immune system cells called T cells, which normally recognize and attack foreign invaders to prevent infection. Some affected individuals also have low numbers of other immune system cells called B cells, which normally help fight infections by producing immune proteins called antibodies (or immunoglobulins). These proteins target foreign invaders and mark them for destruction. The most severely affected individuals, who lack T cells and B cells, have a serious condition called severe combined immunodeficiency (SCID).

The shortage of immune system cells in people with purine nucleoside phosphorylase deficiency results in repeated and persistent infections typically beginning in infancy or early childhood. Infections most commonly affect the respiratory tract and gastrointestinal tract. These infections are often caused by "opportunistic organisms" that ordinarily do not cause illness in people with a normal immune system. The infections can be very serious or life-threatening, and without successful treatment to restore immune function, children with purine nucleoside phosphorylase deficiency usually do not survive past childhood.

Infants with purine nucleoside phosphorylase deficiency typically grow more slowly than healthy babies. About two-thirds of individuals with this condition also have neurological problems, which may include developmental delay, intellectual disability, difficulty with balance and coordination (ataxia), and muscle stiffness (spasticity). People with purine nucleoside phosphorylase deficiency are also at increased risk of developing autoimmune disorders, which occur when the immune system malfunctions and attacks the body's tissues and organs.

Frequency

Purine nucleoside phosphorylase deficiency is rare; only about 70 affected individuals have been described in the medical literature. This disorder accounts for approximately 4 percent of all SCID cases.

Causes & Risk Factors

Purine nucleoside phosphorylase deficiency is caused by mutations in the PNPgene. The PNPgene provides instructions for making an enzyme called purine nucleoside phosphorylase. This enzyme is found throughout the body but is most active in specialized white blood cells called lymphocytes, which include T cells and B cells. Lymphocytes are produced in specialized lymphoid tissues, including the thymus and lymph nodes, and then released into the blood. The thymus is a gland located behind the breastbone; lymph nodes are found throughout the body. Lymphocytes in the blood and in lymphoid tissues are a major component of the immune system.

Purine nucleoside phosphorylase is known as a housekeeping enzyme because it clears away waste molecules that are generated when DNA is broken down. Mutations in the PNPgene reduce or eliminate the activity of purine nucleoside phosphorylase. The resulting excess of waste molecules and further reactions involving them lead to the buildup of a substance called deoxyguanosine triphosphate (dGTP) to levels that can be toxic to cells. Immature T cells in the thymus are particularly vulnerable to a toxic buildup of dGTP, which damages them and triggers their self-destruction (apoptosis). B cells and T cells in other lymphoid tissues can also be damaged. The shortage of T cells and sometimes B cells results in the immune problems characteristic of purine nucleoside phosphorylase deficiency. Damage to brain cells caused by buildup of dGTP is thought to underlie the neurological problems that occur in some people with purine nucleoside phosphorylase deficiency.

Associated Gene

  • PNP

Inheritance

This condition is inherited in an autosomal recessive pattern, which means both copies of the gene in each cell have mutations. The parents of an individual with an autosomal recessive condition each carry one copy of the mutated gene, but they typically do not show signs and symptoms of the condition.

Other Names

  • Nucleoside phosphorylase deficiency
  • PNP deficiency

Frequently Asked Questions

Early signs often include frequent, severe, or unusual infections, especially affecting the respiratory and gastrointestinal tracts, which may be caused by "opportunistic organisms" that don't typically sicken healthy children. Other indicators can be slow growth or developmental delays, and sometimes subtle neurological problems like muscle weakness or coordination issues.
The primary curative treatment is hematopoietic stem cell transplantation (HSCT), often referred to as a bone marrow transplant, which aims to restore a healthy immune system. Enzyme replacement therapy is an investigational treatment. Supportive care includes aggressive management of infections with antibiotics and antifungals, immunoglobulin replacement therapy, and careful monitoring for neurological complications.
Individuals are highly susceptible to severe and life-threatening infections from common bacteria, viruses, and opportunistic organisms (like Pneumocystis jirovecii pneumonia). Emergency care is crucial for any signs of severe infection, such as high fever, difficulty breathing, persistent vomiting or diarrhea, unusual rashes, lethargy, or new neurological symptoms like seizures or changes in consciousness. Prompt medical attention is vital to prevent serious complications.
Diagnosis is typically suspected based on recurrent severe infections and other symptoms. It is confirmed through blood tests that show low numbers of T cells (and sometimes B cells), along with specific biochemical tests measuring purine metabolites in urine or blood, and enzyme activity assays for purine nucleoside phosphorylase. Genetic testing can then identify the specific gene mutation responsible.
Source: MedlinePlus, National Library of Medicine

MedlinePlus brings together authoritative health information from the National Library of Medicine (NLM), the National Institutes of Health (NIH), and other government agencies and health-related organizations.

Meyahealth

Ⓒ 2026. All rights reserved by MEYA